Z. Wee

PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.

Qiang Yu, Jing Tan, Puay Leng Lee, 2013, Cancer discovery.

EZH2-mediated inactivation of IFN-γ-JAK-STAT1 signaling is an effective therapeutic target in MYC-driven prostate cancer.

Qiang Yu, Y. Lim, Puay Leng Lee, 2014, Cell reports.

IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel

H. Ditzel, W. Tam, Qiang Yu, 2015, Nature Communications.

The distal carboxyl terminal of rat NR3B subunit regulates NR1-1a/NR3B and NR1-2a/NR3B surface trafficking

C. Low, Karen Siaw-Ling Wee, Z. Wee, 2010, Neurochemistry International.